SOTAC PHARMACEUTICALS
Back to Balance Sheet
|
SOTAC PHARMACEUTICALS Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹5.76 Cr | ₹1.63 Cr | ₹0.46 Cr | - | ₹0.40 Cr |
What is the latest Contingent Liabilities ratio of SOTAC PHARMACEUTICALS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹5.76 Cr |
| Mar2025 | ₹1.63 Cr |
| Mar2024 | ₹0.46 Cr |
| Mar2023 | - |
| Mar2022 | ₹0.40 Cr |
How is Contingent Liabilities of SOTAC PHARMACEUTICALS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹5.76 Cr | 252.94 | |
| Mar2025 | ₹1.63 Cr | 251.72 | |
| Mar2024 | ₹0.46 Cr | 0 | |
| Mar2023 | - | -100.00 | |
| Mar2022 | ₹0.40 Cr | - | |
Compare Contingent Liabilities of peers of SOTAC PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SOTAC PHARMACEUTICALS | ₹135.2 Cr | -4.7% | 21.7% | -26.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,228.0 Cr | -0.8% | 7.3% | 7.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹296,741.0 Cr | -3.3% | 21.8% | 68.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,413.0 Cr | -1.7% | 1.9% | 22.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,771.0 Cr | 0.7% | 12.4% | 12.4% | Stock Analytics | |
| CIPLA | ₹114,397.0 Cr | 0.7% | 6.7% | -9.4% | Stock Analytics | |
SOTAC PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SOTAC PHARMACEUTICALS | -4.7% |
21.7% |
-26.5% |
| SENSEX | 1.4% |
12.4% |
-1.7% |
You may also like the below Video Courses